Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

Clinical trial NCT05901285 · RECRUITING

Trial details

NCT number: NCT05901285
Sponsor: Vaxiion Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab

Start date: 2023-11-02
Primary completion: 2027-08-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.